Compliance With Once Daily Glaucoma Medication

This study has been completed.
Sponsor:
Collaborators:
Johns Hopkins University
University of Pennsylvania
Information provided by (Responsible Party):
Alcon Research
ClinicalTrials.gov Identifier:
NCT00333463
First received: June 1, 2006
Last updated: April 7, 2012
Last verified: March 2010
  Purpose

A study to examine patient compliance with once daily glaucoma medication


Condition Intervention
Compliance
Behavioral: Intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Compliance With Once Daily Glaucoma Medication

Resource links provided by NLM:


Further study details as provided by Alcon Research:

Estimated Enrollment: 700
Study Start Date: June 2006
Study Completion Date: September 2007
Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Intervention group
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
Behavioral: Intervention
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
No Intervention: Non-Intervention Group
The control group was told to take drops as prescribed and received no additional intervention.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary open angle glaucoma or ocular hypertension patients

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00333463

Locations
United States, Texas
Ft. Worth
Ft. Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
Johns Hopkins University
University of Pennsylvania
Investigators
Study Director: David Friedman, MD Study Director
  More Information

No publications provided

Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT00333463     History of Changes
Other Study ID Numbers: CMS-06-03
Study First Received: June 1, 2006
Last Updated: April 7, 2012
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on April 22, 2014